Canagliflozin Treatment in Patients with Type 2 Diabetes Mellitus

Current guidelines for treatment of type 2 diabetes mellitus (T2DM) indicate a patient-centered approach that should go beyond glycemic control. Of the many antihyperglycemic agents available for treatment of T2DM, sodium-glucose cotransporter 2 (SGLT2) inhibitors offer the advantages of reduced gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Triplitt, Curtis, Cornell, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610726/
https://www.ncbi.nlm.nih.gov/pubmed/26523120
http://dx.doi.org/10.4137/CMED.S31526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610726/
https://www.ncbi.nlm.nih.gov/pubmed/26523120
http://dx.doi.org/10.4137/CMED.S31526

Ejemplares similares